Cancer Immunology and Immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
Bewaard in:
| Coauteur: | |
|---|---|
| Andere auteurs: | |
| Formaat: | Elektronisch E-boek |
| Taal: | English |
| Gepubliceerd in: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2011.
|
| Editie: | 1st ed. 2011. |
| Reeks: | Current Topics in Microbiology and Immunology,
344 |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1007/978-3-642-14136-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Wees de eerste die reageert!